Abstract:Objective·To establish a reliable alcoholic liver disease mouse model (ALDNM) that mimics the drinking pattern of alcoholic liver disease (ALD) patients.Methods·Using the self-designed feeding tubes and liquid diet,ALDNM model was developed through chronic feeding combined with acute gavage of ethanol based on Lieber-DeCarli model and Gao-Binge model.C57BL/6 mice were administered with control liquid diet for adaptation for first 5 d,and then divided into pair-fed group and ethanol-fed group (10 mice each group).Ethanol-fed mice were fed with the liquid diet in which ethanol accounts for 30％ of total energy,while the pair-fed mice were fed with the control diet for 10 d.At the 16th day,ethanol-fed mice and pair-fed mice were respectively gavaged a single dose of 31.5％ ethanol or isocaloric maltose dextrin,and euthanized 9 h later.Sera and livers were collected.The general physiological condition,hepatic tissue pathological changes and serum indexes between Lieber-DeCarli models and ALDNM models were compared.The liver lipids of ALDNM mice were determined by Oil red O (ORO) staining and hepatic triacylglyceride (TAG) test.Meanwhile,the mRNA levels of interleukin-6 (IL-6),tumor necrosis factor α (TNF-α),fatty acid synthase (Fas),long chain fatty acid elongase 6 (Elovl6) and stearyl-CoA desaturase (Scdl) were detected by real-time PCR in ALDNM models.Western blotting was used to detect the changes of phosphorylated signal transduction and transcriptional activator (p-STAT3) in the livers.Results·Lieber-DeCarli model mice were generally in poor condition,and there was no significant change in serum glutamic-pyruvic transaminase (GPT) and glutamic-oxaloacetic transaminase (GOT) compared to pair-fed group.However,in ALDNM models,H-E staining showed that the hepatocytes of ethanol-fed mice were extremely swollen with round volume,increased cytoplasm and filled with large amounts of fat vacuoles.ORO staining analyses showed obvious microsteatosis in the liver cells from all ethanol-fed mice.The hepatosomatic index,liver TAG content,serum GPT and GOT of ALDNM models were significantly higher than those in the pair-fed group,while the serum HDL significantly decreased compared to the pair-fed group.Moreover,the expression levels of both lipid synthesis pathways and inflammatory signaling pathways related genes in livers significantly increased in the ethanol-fed mice of ALDNM model.Conclusion·ALDNM model was successfully constructed.This model is cost-and time-efficient.Moreover,ALDNM model mimics the drinking pattern and pathogenesis of ALD patients with the advantages of stable food intake,good repeatability,and obvious liver damage.

A Liver-Chip-based Alcoholic Liver Disease Model Featuring Multi-Non-parenchymal Cells.

Synergistic Modulation of a Tunable Microenvironment to Fabricate a Liver Fibrosis Chip for Drug Testing.

Development of alcoholic liver disease model for drug evaluation from human induced pluripotent stem cell derived liver organoids

Noncoding RNAs in Alcoholic Liver Disease

A Liver Analog Construct for Use As an Alcoholic Liver Disease Model

Hydrogel Microfluidic‐based Liver‐on‐a‐chip: Mimicking the Mass Transfer and Structural Features of Liver

A pumpless liver-on-a-chip for drug hepatotoxicity analysis

Tissue Engineered Artificial Liver Model Based on Viscoelastic Hyaluronan-Collagen Hydrogel and the Effect of EGCG Intervention on ALD

Advancements in the Alcohol-Associated Liver Disease Model

Modeling nonalcoholic fatty liver disease on a liver lobule chip with dual blood supply

Construction of a New Alcoholic Liver Disease Mouse Model

Analysis of Differentially Expressed Genes and Micrornas in Alcoholic Liver Disease

Modeling alcohol-associated liver disease in humans using adipose stromal or stem cell-derived organoids

Engineered Liver-on-a-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: A Review

A multicellular liver organoid model for investigating hepatitis C virus infection and nonalcoholic fatty liver disease progression

A Liver-on-a-chip for Hepatoprotective Activity Assessment.

Animal Models of Alcoholic Liver Disease: Pathogenesis and Clinical Relevance.

Rhesus Monkey Model Of Liver Disease Reflecting Clinical Disease Progression And Hepatic Gene Expression Analysis

Integrated-gut-liver-on-a-chip platform as an in vitro human model of non-alcoholic fatty liver disease

Development of a Biomimetic Liver Tumor-on-a-chip Model Based on Decellularized Liver Matrix for Toxicity Testing.

Myeloid Cells in Alcoholic Liver Diseases: Mechanism and Prospect